logo-loader
viewOpen Orphan PLC

Venn Life Sciences Holdings PLC beat forecasts on rising contract sizes, says chief

Venn Life Sciences Holdings PLC (LON:VENN) has forecast better-than-expected annual results after winning bigger contracts this year.

Tony Richardson, chief executive, tells Proactive Investors the company has “moved from the realm of a typical contract size being €300,000/€400,000/€500,000 per piece,” to “a pipeline that has a lot more multi million euro pieces of business in it.”

He says the company is seeing a “healthy mix” of both recurring revenue from existing clients as well as a “nice pattern” of referrals or recommendations from existing customers to new potential clients.

Quick facts: Open Orphan PLC

Price: 14.82 GBX

AIM:ORPH
Market: AIM
Market Cap: £89.24 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Open Orphan PLC named herein, including the promotion by the Company of Open Orphan PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Innovenn split will ‘maximise shareholder value’, says Venn CEO

Venn Life Sciences Holdings plc (LON:VENN) chief executive Tony Richardson says that separating Innovenn from its core business simplifies the firm and generates more value for shareholders. Speaking exclusively to Proactive, Richardson says: “Spinning [Innovenn] out, we believe, will...

on 5/10/16

2 min read